Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94
about
In Vitro Anti-Cytomegalovirus Activity of Kampo (Japanese Herbal) MedicinePhenotypic drug susceptibility assay for influenza virus neuraminidase inhibitorsAn epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection.Conserved herpesvirus protein kinases.The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.Preparation and ocular pharmacokinetics of ganciclovir liposomes.Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections.The search for new therapies for human cytomegalovirus infections.Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replicationNovel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice
P2860
Q24808870-BB25024A-E729-4E4D-A525-12FCA2B028D3Q30450742-2EEE62D6-28E1-4603-8384-047A1BAAC732Q33887700-BD0850B6-EE0E-4E13-8474-D1D52A35DF9EQ35103227-D28EFC1E-EF86-4B42-9331-ED7DEA5B4499Q35315818-804617B0-2876-437D-9CDE-B7D05E644C78Q36491044-0656DE81-F36A-4A29-8FAD-193BD2346756Q36827232-507E390C-CD00-46A9-8DFD-3ECC30B88731Q37361985-68C42AC0-6C41-46EF-A982-F4BD0A4F6A71Q37478310-0726BE42-C4B3-4247-94B8-54B2A720379DQ37734561-9DA8A803-8E1C-43B5-A3B6-27D2804D007AQ37811458-865901AF-597D-4AD7-8D6F-28703569F84DQ39798789-781FA989-7912-4373-8808-CF99CD12F30DQ40289512-8A93DF14-39CA-4727-A25A-4D161B338334Q41818018-595A4BDD-1DBA-484C-89F6-BF142A90511F
P2860
Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@ast
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@en
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@nl
type
label
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@ast
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@en
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@nl
prefLabel
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@ast
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@en
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@nl
P2093
P2860
P1476
Inhibition of ganciclovir-susc ...... nzimidazole L-riboside 1263W94
@en
P2093
P2860
P304
P356
10.1128/CDLI.8.6.1279-1281.2001
P407
P577
2001-11-01T00:00:00Z